Professor Anna Schuh

Professor Anna Schuh is the Director of Molecular Diagnostics at the University of Oxford and an honorary consultant haematologist. She has participated as a principle or chief investigator in over 30 early- or late-phase clinical trials in chronic lymphocytic leukaemia. A number of these led to subsequent NICE approvals and have changed clinical practice in the UK and worldwide. As the Director of the Oxford NIHR Molecular Diagnostics Centre (MDC), she receives grants from the NIHR, Wellcome Trust, Technology Strategy Board and Bloodwise.

Her primary research interest is with the development, evaluation and implementation of new technologies for precision diagnostics with a particular focus on genomics. She leads the Genomics England Clinical Interpretation Partnership for Haematological Malignancies on behalf of the NCRN clinical investigators and has authored or co-authored over 80 peer-reviewed publications in the last five years.